Lyme Borreliosis
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population (NCT04801420) | Pfizer | 2021-03-08 |
| Place of Intrathecal CXCL-13 in the Diagnosis of Lyme Neuroborreliosis (NCT05625100) | University Hospital, Strasbourg, France | 2020-07-13 |
| Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis (NCT03873974) | Lyme Diagnostics Ltd. | 2019-07-02 |
| Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis (NCT03970733) | Pfizer | 2019-07-01 |
| Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. (NCT03769194) | Pfizer | 2018-12-17 |
| Doxycycline in Therapy of Erythema Migrans (NCT01475708) | University Medical Centre Ljubljana | 2011-05-01 |
| Borrelia Species in Cutaneous Lyme Borreliosis (NCT00576082) | University Hospital, Strasbourg, France | 2008-03-01 |
Track Lyme Borreliosis automatically
Every clearance here is in the API, with alerts when new ones post.